我們已在上線! 進一步了解
NMTR

9 Meters Biopharma

已下市

NMTR已於2023年7月25日下市。

 

關於: 9 Meters Biopharma Inc is a clinical-stage biopharmaceutical company focused on rare and unmet needs in gastroenterology. Its pipeline includes drug candidates for short bowel syndrome (SBS), celiac disease, and three early-stage candidates for undisclosed rare diseases and/or unmet needs. Its products include NM-002, Larazotide, NM-003, and others.

員工: 10

新聞

正面
中性
負面
市場情緒 3個月
正面 0%
中性 0%
負面 0%

我們尚未收到任何關於NMTR的最新新聞文章。

價格圖表採用Lightweight Charts™實作